Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956095 · ClinicalTrials.gov registry record
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT03956095: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03956095 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956095 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if it is possible to establish a nutritional support program for people who are scheduled to receive primary debulking surgery. Design: This will be a prospective observational study to assess the feasibility of implementing a preoperative nutrition supplementation program.
Interventions
- DIETARY_SUPPLEMENT Ensure Surgery Immunonutrition Shake supplements
- OTHER Daily Food Intake form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2025-12-19 |
What the finished NCT03956095 record still lists
NCT03956095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Ensure Surgery Immunonutrition Shake supplements is the first listed.
NCT03956095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956095 about?
NCT03956095 is a clinical study titled "Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer". The purpose of this study is to find out if it is possible to establish a nutritional support program for people who are scheduled to receive primary debulking surgery. Design: This will be a prospective observational study to assess the feasibility of implementing a preoperative nutrition suppleme...
What is the current status of trial NCT03956095?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-05-16. Estimated completion is 2025-12-19.
What interventions are being tested in trial NCT03956095?
The interventions under investigation include: Ensure Surgery Immunonutrition Shake supplements (DIETARY_SUPPLEMENT), Daily Food Intake form (OTHER).
Who is sponsoring clinical trial NCT03956095?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI